Screener
Solid Biosciences Inc. SLDB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
FAQ
- What is Solid Biosciences Inc.'s EPS (diluted)?
- Solid Biosciences Inc. (SLDB) reported EPS (diluted) of -$0.38 in Q2 2026.
- How has Solid Biosciences Inc.'s EPS (diluted) changed year-over-year?
- Solid Biosciences Inc.'s EPS (diluted) increased by 9.5% year-over-year, from -$0.42 to -$0.38.
- What is the long-term trend for Solid Biosciences Inc.'s EPS (diluted)?
- Over 4 years (2021 to 2025), Solid Biosciences Inc.'s EPS (diluted) has grown at a -21.1% compound annual growth rate (CAGR), from -$5.22 to -$2.02.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Solid Biosciences Inc.'s eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude